SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending after halting its compounded weight-loss pill offering due to regulatory pressure, sparking widespread community debate over potential short squeezes, management's competence, and the long-term outlook for its diverse telehealth platform despite a recent Super Bowl ad.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is drawing intense attention following a substantial financing amendment that extends its capital runway through 2028, alongside a new collaboration in cotton traceability. This has fueled a sharp divide among traders, with many anticipating a major short squeeze and a repeat of its history of massive price surges, while others warn of a 'dilution machine' and typical crashes after such momentum.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending with high anticipation for its upcoming Q4 earnings report, as investors weigh its AI-driven, capital-light model against broader fintech sector headwinds and perceived market manipulation. The community is actively discussing the stock's significant undervaluation and potential for a short squeeze, even as some express caution regarding historical post-earnings volatility.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending due to widespread anticipation surrounding a potential POSCO partnership and forthcoming Q4 earnings, with the community actively debating the implications of a recent share dilution and robust HRC prices amidst high short interest. Many speculate on a significant upside driven by these catalysts and supportive tariffs.

Edgewell Personal Care Co. engages in the manufacturing and marketing of personal care products. It operates through the following segments: Wet Shave, Sun and Skin Care, and Feminine Care. The Wet Shave segment involves Schick, Wilkinson Sword, edge, Skintimate, Billie, and Shave Guard. The Sun and Skin Care segment consists of Banana Boat, Hawaiian Tropic, and Wet Ones. The Feminine Care segment refers to Playtex, Stayfree, and Carefree. The company was founded on September 23, 1999 and is headquartered in Shelton, CT.

Edgewell Personal Care Co

Edgewell Personal Care is trending following its recent Q1 '26 earnings, which reported a decline in GAAP EPS and revenue, coupled with a revised fiscal 2026 outlook reflecting the divestiture of its feminine care business. The community is actively discussing ongoing operational credibility concerns, profitability challenges in a competitive consumer market, and renewed speculation surrounding potential strategic moves or a company buyout.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is a focal point as its strategic acquisition in physical AI sensing, strong revenue growth, and robust balance sheet bolster its leadership within a consolidating lidar market. The community is actively debating its diversified impact across robotics and smart infrastructure, increasingly viewing it as a foundational technology for the expanding physical AI revolution.

Arbor Realty Trust, Inc. operates as a real estate investment trust, which engages in the provision of loan origination and servicing for multifamily, seniors housing, healthcare, and diverse commercial real estate assets. It operates through the Structured Business and Agency Business segments. The Structured Business segment offers a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets. The Agency Business segment focuses on the sale and service of a range of multifamily finance products through the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation. The company was founded by Ivan Kaufman in June 2003 and is headquartered in Uniondale, NY.

Arbor Realty Trust Inc.

Arbor Realty Trust is trending due to a recent credit rating upgrade and significant insider buying, as the community actively debates whether anticipated interest rate cuts will trigger a short squeeze in the heavily-shorted mortgage REIT.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the inauguration of its Eagle Line pilot production facility, signaling a crucial transition from R&D to scalable manufacturing, which is fueling community speculation about new OEM partnerships and its disruptive potential ahead of upcoming earnings.

The Kroger Co. engages in the retail grocery business with added convenience to retail pharmacies and fuel centers. Its main focus is on growing households and increasing customer loyalty by delivering great value and convenience, and investing in four strategic pillars: Fresh, Brands, Data & Personalization and Seamless. Its brands include Big K, Smart Way, Heritage Farm, Simple Truth, and Simple Truth Organic. The company was founded by Barney Kroger in 1883 and is headquartered in Cincinnati, OH.

Kroger Co.

Kroger is trending as investors rally behind reports of retail veteran Greg Foran, former Walmart U.S. CEO, taking the helm, seeing his proven operational expertise as key to a fresh strategy in the highly competitive grocery market.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton Dickinson & Co.

Becton, Dickinson And Co.

BDX is trending due to a strong Q1'26 earnings beat and reaffirmed guidance, alongside significant strategic portfolio shifts. Investors are closely watching the imminent completion of the Biosciences unit's merger with Waters Corp and the recent acquisition of Edwards Lifesciences' Critical Care group, which aim to propel the company into focused growth areas like advanced diagnostics and connected care.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Emily Leproust Sells 5,001 Shares of Twist Bioscience (NASDAQ:TWST) Stock

Twist Bioscience Corporation (NASDAQ:TWST - Get Free Report) CEO Emily Leproust sold 5,001 shares of Twist Bioscience stock in a transaction dated Tuesday, February 3rd. The shares were sold at an...

IQ EQ FUND MANAGEMENT IRELAND Ltd Acquires 126,260 Shares of Twist Bioscience Corporation $TWST

IQ EQ FUND MANAGEMENT IRELAND Ltd raised its holdings in Twist Bioscience Corporation (NASDAQ:TWST - Free Report) by 90.4% during the 3rd quarter, according to its most recent filing with the...

Twist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 1,099 Shares of Stock

Twist Bioscience Corporation (NASDAQ:TWST - Get Free Report) insider Dennis Cho sold 1,099 shares of the company's stock in a transaction on Tuesday, February 3rd. The stock was sold at an average...

Twist Bioscience (NASDAQ:TWST) SVP Paula Green Sells 1,194 Shares

Twist Bioscience Corporation (NASDAQ:TWST - Get Free Report) SVP Paula Green sold 1,194 shares of the business's stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average...

Twist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 5,001 Shares of Stock

Twist Bioscience Corporation (NASDAQ:TWST - Get Free Report) CEO Emily Leproust sold 5,001 shares of the firm's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an...

Twist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 7,000 Shares

Twist Bioscience Corporation (NASDAQ:TWST - Get Free Report) CAO Robert Werner sold 7,000 shares of the company's stock in a transaction dated Wednesday, February 4th. The shares were sold at an...

These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results

Twist Bioscience Corporation $TWST Stake Raised by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans grew its holdings in shares of Twist Bioscience Corporation (NASDAQ:TWST - Free Report) by 14.5% in the 3rd quarter, according to the company in its most recent...

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (Twist or the Company), a mid-cap growth and value biotech company, today announced that a total of...

<ul class="summary-bullets"><li>For the full fiscal year 2026, the company now expects total revenue in the range of $435 million to $440 million, compared to prior guidance of $425 to $435 million.</li><li>For the current quarter (Q2), the company expects to report revenue of approximately $107 million to $108 million, marking a growth of approximately 16% percent year over year.</li><li>Twist also said that it expects to achieve adjusted EBITDA breakeven in the fourth quarter of fiscal 2026.</li></ul><p>Shares of Twist Bioscience Corporation (TWST) jumped 8% on Monday after the company hiked its fiscal year 2026 revenue guidance on the heels of a first-quarter (Q1) earnings report that beat Wall Street estimates.</p><h2 class="st-heading-2">Upbeat Outlook</h2><p>For the full fiscal year 2026, the company now expects total revenue in the range of $435 million to $440 million, compared to prior guidance of $425 to $435 million, and exceeding an analyst estimate of $430.84 million, according to data from Fiscal AI. &nbsp;</p><p>For the current quarter (Q2), the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.twistbioscience.com/static-files/af6dbd56-d91e-429e-b337-a8e2675fc255">expects</a> to report revenue of approximately $107 million to $108 million, marking a growth of about 16% percent year over year at the midpoint, and exceeding an estimated $105.08 million.</p><p>Twist also said that it expects to achieve adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) breakeven in the fourth-quarter of fiscal 2026.</p><h2 class="st-heading-2">Q1 Numbers</h2><p>For Q1, the company reported total revenue of $103.7 million, marking a growth of 17%, and above an expected $100.33 million, due to an increase in customers. The company said that it shipped products to about 2,538 customers in Q1 of fiscal 2026, versus approximately 2,376 in the same quarter of the previous fiscal year.</p><p>Net loss for the quarter came in at $30.5 million, compared to $31.6 million in the corresponding quarter of fiscal 2025.</p><p>The company also ended the quarter with $198 million in cash, cash equivalents, and short-term investments.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around TWST stock rose from ‘bearish’ to ‘neutral’ territory over the past 24 hours, while message volume remained at ‘high’ levels.</p><p>A user applauded the earnings as “solid” progress for investors.</p><p><stembedurl>https://www.stocktwits.com/DBRGLong/message/643661292</stembedurl></p><p><a href="https://stocktwits.com/symbol/TWST">TWST stock</a> has dropped 16% over the past 12 months.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/oracle-bond-offering-funding-ai-cloud-infrastructure/cZbgYA1R4ki">ORCL Stock In Focus As Tech Giant Reportedly Launches Bond Offering To Cover Half Of 2026 Funding Needs</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Rising stock market chart on a trading board background.

TWST Shares Rise 8% — What’s Driving The Rally?

Twist Bioscience Corporation hiked its fiscal year 2026 revenue guidance on the heels of a first quarter earnings report that beat Wall Street estimates. 

Equity

Twist Bioscience Corporation hiked its fiscal year 2026 revenue guidance on the heels of a first quarter earnings report that beat Wall Street estimates. 


Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$49.24
Prev Close	$47.10
Open	$48.72
Dividend Yield	0.00%
50-Day Moving Average	$36.66
Beta	2.28
Avg. Volume	1.32M
PE Ratio	-38.63

52-Week High	$51.80
52-Week Low	$23.30
Market Capitalization	$3.02B
EPS (Annual)	-$1.30
Price to Book	6.62
Revenue Per Employee	$384,649.64
Enterprise Value/EBITDA	N/A

TWST
Twist Bioscience Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TWST News

TWSTTwist Bioscience Corp